Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells

Cancer Res. 1999 Aug 1;59(15):3581-7.

Abstract

The FRAP-p70s6K signaling pathway was found to be constitutively phosphorylated/active in MiaPaCa-2 and Panc-1 human pancreatic cancer cells and a pancreatic cancer tissue sample as judged by the retarded electrophoretic mobility of the two major FRAP downstream targets, p70s6K and 4E-BP1. Treatment of cells with rapamycin, a selective FRAP Inhibitor, inhibited basal p70s6K kinase activity and induced dephosphorylation of p70s6K and 4E-BP1. Moreover, rapamycin inhibited DNA synthesis as well as anchorage-dependent and -independent proliferation in MiaPaCa-2 and Panc-1 cells. Finally, rapamycin strikingly inhibited cyclin D1 expression in pancreatic cancer cells. Thus, inhibitors of the constitutively active FRAP-p70s6K pathway may provide a novel therapeutic approach for pancreatic cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium-Calmodulin-Dependent Protein Kinases / physiology
  • Carcinoma / enzymology
  • Carcinoma / pathology*
  • Cell Cycle / drug effects
  • Cell Cycle Proteins*
  • Culture Media, Serum-Free / pharmacology
  • Cyclin D1 / biosynthesis*
  • Cyclin D1 / genetics
  • Cyclin E / metabolism
  • Cyclin-Dependent Kinase Inhibitor p27
  • Humans
  • Microtubule-Associated Proteins / metabolism
  • Mitogen-Activated Protein Kinase 1
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / physiology*
  • Pancreatic Neoplasms / enzymology
  • Pancreatic Neoplasms / pathology*
  • Phosphorylation / drug effects
  • Phosphotransferases (Alcohol Group Acceptor) / physiology*
  • Protein Kinases*
  • Protein Processing, Post-Translational / drug effects
  • Ribosomal Protein S6 Kinases / physiology*
  • Signal Transduction / physiology*
  • Sirolimus / pharmacology*
  • TOR Serine-Threonine Kinases
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • Tumor Suppressor Proteins*

Substances

  • Cell Cycle Proteins
  • Culture Media, Serum-Free
  • Cyclin E
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • Tumor Suppressor Proteins
  • Cyclin D1
  • Cyclin-Dependent Kinase Inhibitor p27
  • Protein Kinases
  • Phosphotransferases (Alcohol Group Acceptor)
  • MTOR protein, human
  • Ribosomal Protein S6 Kinases
  • TOR Serine-Threonine Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Sirolimus